CARGO Therapeutics (CRGX) announced that its first abstract on CRG-023 will be presented as a poster at the upcoming 66th American Society of Hematology Annual Meeting and Exposition, taking place ...

Kymera Therapeutics (KYMR) announced that it recently initiated dosing in the Phase 1 clinical trial in the US evaluating KT-621, a potent, selective, oral degrader of STAT6, in adult healthy ...

A Chicago apartment complex could be headed to foreclosure after the owners fell behind on debt payments and tried but failed to sell it ahead of the maturity date on its $39 million loan.